Baclofen and Vitamin d2 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Baclofen (baclofen) and Vitamin d2 (ergocalciferol). Common drug interactions include unresponsive to stimuli among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Baclofen and Vitamin d2. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Baclofen?

Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.

What is Vitamin d2?

Vitamin d2 has active ingredients of ergocalciferol. eHealthMe is studying from 979 Vitamin d2 users. Check the latest studies of Vitamin d2.

On Jul, 11, 2026

45 people who take Baclofen and Vitamin d2 together, and have interactions are studied.

Baclofen and Vitamin d2 drug interactions.

What are the common drug interactions of Baclofen and Vitamin D2, by gender? *:

female:

Unresponsive to stimuli
Weight decreased
Anxiety
Depression
Fatigue (feeling of tiredness)
Asthenia (weakness)
Depressed mood
Dizziness
Dry mouth
Flushing (the warm, red condition of human skin)

male:

Fatigue (feeling of tiredness)
Chronic kidney disease
Depression
Poor quality sleep
Renal failure (kidney dysfunction)
Somnambulism (sleep walking)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the common drug interactions of Baclofen and Vitamin D2, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anxiety
Depression
Dizziness
Fatigue (feeling of tiredness)
Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
Insomnia (sleeplessness)
Intervertebral disc protrusion (spinal disc protrusion)
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

30-39:

Altered state of consciousness (altered state of mind)
Decreased appetite
Device dislocation
Unresponsive to stimuli
Weight decreased
Chronic kidney disease
Depression
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

40-49:

Fatigue (feeling of tiredness)
Dizziness
Dry mouth
Flushing (the warm, red condition of human skin)
Palpitations (feelings or sensations that your heart is pounding or racing)
Somnolence (a state of near-sleep, a strong desire for sleep)
Anxiety
Asthenia (weakness)
Chronic kidney disease
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)

50-59:

Liposarcoma (a cancer tumour that arises in fat cells in deep soft tissue)
Migraine (headache)
Muscular weakness (muscle weakness)
Osteopenia (a condition where bone mineral density is lower than normal)
Paraparesis (partial paralysis of the lower limbs)
Rash
Asthenia (weakness)
Cervical cord compression (compression of spinal cord at site of cervical vertebrae)
Chronic kidney disease
Dry mouth

60+:

Spinal column stenosis (narrowing of spinal column)
Spinal osteoarthritis (joint cartilage loss in spine)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 21 people, 46.67%
Pain: 6 people, 13.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 11.11%
Multiple Myeloma (cancer of the plasma cells): 5 people, 11.11%
Stress And Anxiety: 4 people, 8.89%
Migraine (headache): 4 people, 8.89%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.89%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 8.89%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 6.67%
Nausea (feeling of having an urge to vomit): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Baclofen and Vitamin d2?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously